Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other



Shendelman Shoshana Create: Alert

All | News | Filings
Date FiledTypeDescription
09/29/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/28/2023 SC 13D/A Shendelman Shoshana reports a 13.3% stake in APPLIED THERAPEUTICS, INC.
01/13/2023 4 Shendelman Shoshana (President and CEO) has filed a Form 4 on Applied Therapeutics Inc.
Txns: Sold 15,870 shares @ $0.91, valued at $14.4k
Granted 1,964,362 shares @ $0
10/14/2022 4 Shendelman Shoshana (President and CEO) has filed a Form 4 on Applied Therapeutics Inc.
Txns: Bought 50,000 shares @ $0.645, valued at $32.3k
10/14/2022 SC 13D/A Shendelman Shoshana reports a 14.9% stake in APPLIED THERAPEUTICS, INC.
10/13/2022 4 Shendelman Shoshana (President and CEO) has filed a Form 4 on Applied Therapeutics Inc.
Txns: Bought 73,256 shares @ $0.5582, valued at $40.9k
10/12/2022 4 Shendelman Shoshana (President and CEO) has filed a Form 4 on Applied Therapeutics Inc.
Txns: Bought 38,153 shares @ $0.5227, valued at $19.9k
08/04/2022 4 Shendelman Shoshana (President and CEO) has filed a Form 4 on Applied Therapeutics Inc.
Txns: Disposed/sold 234,616 options to buy @ $3.33, valued at $781.3k
Disposed/sold 234,616 options to buy @ $1.05, valued at $246.3k
Disposed/sold 101,670 options to buy @ $23.15, valued at $2.4M
Disposed/sold 101,670 options to buy @ $1.05, valued at $106.8k
Disposed/sold 134,979 options to buy @ $22.2, valued at $3M
Disposed/sold 134,979 options to buy @ $1.05, valued at $141.7k
Disposed/sold 23,317 options to buy @ $22.2, valued at $517.6k
Disposed/sold 23,317 options to buy @ $1.05, valued at $24.5k
Disposed/sold 607,484 options to buy @ $10, valued at $6.1M
Disposed/sold 607,484 options to buy @ $1.05, valued at $637.9k
01/28/2022 SC 13D/A Shendelman Shoshana reports a 25% stake in APPLIED THERAPEUTICS, INC.
01/27/2022 4 Shendelman Shoshana (President and CEO) has filed a Form 4 on Applied Therapeutics Inc.
Txns: Granted 234,616 options to buy @ $3.33, valued at $781.3k
01/11/2022 4 Shendelman Shoshana (President and CEO) has filed a Form 4 on Applied Therapeutics Inc.
Txns: Granted 120,900 shares @ $0
Granted 80,600 options to buy @ $4.17, valued at $336.1k
01/11/2022 4/A Shendelman Shoshana (President and CEO) has filed a Form 4 on Applied Therapeutics Inc.
Txns: Granted 120,900 shares @ $0
12/16/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/16/2021 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
02/16/2021 5 Shendelman Shoshana (President and CEO) has filed a Form 5 on Applied Therapeutics Inc.
12/14/2020 4 Shendelman Shoshana (President and CEO) has filed a Form 4 on Applied Therapeutics Inc.
Txns: Granted 256,850 options to buy @ $23.15, valued at $5.9M
11/13/2020 3 Shendelman Shoshana (Director) has filed a Form 3 on 180 Life Sciences Corp.
08/14/2020 SC 13D/A Shendelman Shoshana reports a 26.5% stake in APPLIED THERAPEUTICS, INC.
07/22/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/09/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/01/2020 4 Shendelman Shoshana (President and CEO) has filed a Form 4 on Applied Therapeutics Inc.
Txns: Gifted 290,280 shares @ $0
Gifted 709,720 shares @ $0
Gifted 290,280 shares @ $0
Gifted 709,720 shares @ $0
Sold 125,000 shares @ $42.7, valued at $5.3M
Exercised 27,624 options to buy @ $1, valued at $27.6k
Exercised 97,376 options to buy @ $1.44, valued at $140.2k
06/01/2020 SC 13D/A Shendelman Shoshana reports a 27% stake in APPLIED THERAPEUTICS, INC.
02/14/2020 5 Shendelman Shoshana (President and CEO) has filed a Form 5 on Applied Therapeutics Inc.
12/18/2019 4 Shendelman Shoshana (President and CEO) has filed a Form 4 on Applied Therapeutics Inc.
Txns: Granted 209,000 options to buy @ $22.2, valued at $4.6M
Granted 23,317 options to buy @ $22.2, valued at $517.6k
05/29/2019 4/A Shendelman Shoshana (President and CEO) has filed a Form 4 on Applied Therapeutics Inc.
Txns: Converted 88,397 shares @ $0
Converted 88,397 preferred shares @ $0
05/29/2019 3/A Shendelman Shoshana (President and CEO) has filed a Form 3/A on Applied Therapeutics Inc.
05/29/2019 SC 13D Shendelman Shoshana reports a 32.4% stake in APPLIED THERAPEUTICS, INC.
05/20/2019 4 Shendelman Shoshana (President and CEO) has filed a Form 4 on Applied Therapeutics Inc.
Txns: Bought 125,000 shares @ $10, valued at $1.3M
05/15/2019 4 Shendelman Shoshana (President and CEO) has filed a Form 4 on Applied Therapeutics Inc.
Txns: Granted 767,349 options to buy @ $10, valued at $7.7M
05/13/2019 3 Shendelman Shoshana (President and CEO) has filed a Form 3 on Applied Therapeutics Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy